Logo
日
Arrow
EN简ESPT日
XCEED LoginConnect Now
Logo
日
Arrow
EN简ESPT日
Arrow
Therapy Area arrow
Dosage Form arrow
Dossier Status arrow
Filed-ja
Oral

Linagliptin

Anti-Diabetic

  • 5 mg
開発中で
Oral

Sitagliptin HCL + Metformin

Anti-Diabetic

  • 50 + 500
  • 50 + 850
Filed-ja
Oral

Linagliptin + Metformin

Anti-Diabetic

  • 2.5 mg/500 mg
  • 2.5 mg/850 mg
  • 2.5 mg/1000 mg
Filed-ja
Oral

Sitagliptin HCL

Anti-Diabetic

  • 25
  • 50
  • 100 mg
Filed-ja
Oral

Sitagliptin Phosphate

Anti-Diabetic

  • 25
  • 50 and 100 mg
Filed-ja
Oral

Sitagliptin Phosphate + Metformin

Anti-Diabetic

  • 50 + 500
  • 50 + 1000 mg
開発中で
Injectable

Liraglutide

Anti-Diabetic

  • 6 mg/ml (3 ml)
開発中で
Injectable

Liraglutide

Anti-Obesity

  • 6 mg/ml (3 ml)
  • ...
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.